Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Blinded, Saline-Controlled Trial of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System

NCT01011816 is registered in ClinicalTrials.gov with Spinal Restoration, Inc. as lead sponsor.

NCT NCT01011816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Blinded, Saline-Controlled Trial of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System
Lead sponsor
Spinal Restoration, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2010
Completion date
May 31, 2013
Enrollment
220 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, chronic low back pain, degenerative disc disease, internal disc disruption